Xpect Stopain Clinical Gel
NDC Package 42961-256-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Xpect Stopain Clinical (menthol) gel is adults and children 2 years of age and older:apply directly onto affected area without the need to bandagerepeat if necessary, but do not apply more than 3 to 4 times dailyChildren under 2 years of age: do not use, consult a doctor. This formulation utilizes a gel delivery system. Marketed by Cintas Corporation, this product is identified by NDC 42961-256 and is authorized under FDA application M017.

Identification & Billing

NDC Package Code
42961-256-01
Package Description
3 g in 1 PACKET
Product Code
42961-256
11-Digit Billing Format
42961025601
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Xpect Stopain Clinical
Non-Proprietary Name
Menthol
Substance Name
Menthol
Dosage Form
Gel - A semisolid3 dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion.4 A gel may contain suspended particles.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
MENTHOL 100 mg/g
Usage Information
Adults and children 2 years of age and older:apply directly onto affected area without the need to bandagerepeat if necessary, but do not apply more than 3 to 4 times dailyChildren under 2 years of age: do not use, consult a doctor.

Regulatory & Marketing

Labeler Name
Cintas Corporation
Product Type
Human Otc Drug
FDA Application #
M017
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
06-14-2024
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (42961-256). Click a package code to view its specific billing and regulatory data.

42961-256-02
5 PACKET in 1 BAG / 3 g in 1 PACKET (42961-256-01)

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 42961-256-01 identifies a specific commercial package of 3 g in 1 packet of Xpect Stopain Clinical, a human over the counter drug labeled by Cintas Corporation. This gel is formulated for topical use and contains menthol as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cintas Corporation on June 14, 2024. The current certification is valid through December 31, 2027.

How is this Cintas Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 42961025601. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
42961-256-01
11-Digit CMS (5-4-2)
42961-0256-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.